Form 4 for BDX Becton Dickinson
Accepted 2026-08-12 17:27:20 ET · period of report 2026-08-11 · accession 0001628280-26-056366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 17:27 | 2026-08-11 | BDX | Goette Roland | EVP, Pres, EMEA | S - Sale | $180.84 | -2,438 | 14.9K | -14% | -$440.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-11 | S | D | 2,438 | $180.84 | 14,856 | D | — | — | (F1) Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). (F2) Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. |